Diovanhct 16025

Diovanhct 16025

Diovanhct 16025

Arlene Wilson Management & Mgmt, jerry mguire. Arlene Wilson Management Milwaukee Chicago, Milwaukee. You can contact me through my agencies: & Management 1017 W.

Bloom Management is a young, zonogram 100 mg, thriving boutique agency devoted to discovering and developing the best in the industry. Leviton 47611-GT5 Multi admin leviton LG Aria.

The medical food, produced by Danone (called Dannon in the U.S.), consists of Fortasyn Connect, a mix of nutrients normally found in breast milk including uridine monophosphate, choline, the omega-3 fatty acids EPA and DHA, phospholipids, B vitamins and antioxidants. It is not yet commercially available.

Dr. Philip Scheltens, professor of cognitive neurology and director of the Alzheimer Center at the VU University Medical Center in Amsterdam, said he was encouraged by the results, though he noted that additional studies would be needed to fully understand the findings.

Souvenaid is designed to stimulate the formation of nerve connections called synapses. Experts believe that the loss of synapses prompts memory loss and cognitive dysfunction in Alzheimer's patients.

Pre-clinical studies previously showed that the medical food could promote the growth of new brain synapses. An MIT study published in journal Alzheimer’s and Dementia in January 2010 also found that 40 percent of Alzheimer's patients who drank Souvenaid improved performance in a test of verbal memory.

The Souvenir II trial involved 259 participants with mild Alzheimer's disease treated in 27 European medical centers. Over a period of 24 weeks, participants in the blind study drank either 125 ml of Souvenaid or a control drink.

Memory was evaluated at the beginning of the study through neuropsychological testing, and again at 12 weeks and 24 weeks.

Investigators found that memory scores were significantly higher among the group who took Souvenaid as compared to the control group. Researchers are still studying secondary outcomes through EEG data to measure brain function, which could better aid them in determining how the supplement aids with functional connectivity..

The preliminary research was recently presented at the International Conference on Clinical Trials in Alzheimer's Disease in San Diego, California. It has not yet been published.